| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 211 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 173 |
| 2 | TACROLIMUS OINTMENT 0.1% | 173 |
| 3 | MYCOPHENOLATE MOFETIL | 170 |
| 4 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 170 |
| 5 | PREDNISOLONE | 170 |
| 6 | PREDNISOLONE ORAL | 170 |
| 7 | PREDNISOLONE ORAL SOLUTION | 170 |
| 8 | PREDNISONE | 165 |
| 9 | GEMCITABINE HYDROCHLORIDE | 163 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANHYDROUS CITRIC ACID, SODIUM BICARBONATE, AND ASPIRIN | 1 | 0.0714 |
| 1 | STREPTOZOCIN | 15 | 0.0652 |
| 2 | ETHIODIZED OIL | 73 | 0.0562 |
| 3 | PORFIMER SODIUM | 9 | 0.0264 |
| 4 | THROMBIN HUMAN AND FIBRINOGEN | 7 | 0.0208 |
| 5 | ADENINE | 1 | 0.0204 |
| 6 | CASPOFUNGIN ACETATE | 26 | 0.0164 |
| 7 | BENZETHONIUM CHLORIDE 0.13% | 1 | 0.0152 |
| 8 | VANCOMYCIN HYDROCHLORIDE | 102 | 0.0122 |
| 9 | PENICILLIN G SODIUM | 14 | 0.0121 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 548 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 289 |
| 2 | Platinum-based Drug [EPC] | 257 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 243 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 213 |
| 5 | Kinase Inhibitor [EPC] | 210 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 160 |
| 7 | Proton Pump Inhibitor [EPC] | 147 |
| 8 | Alkylating Drug [EPC] | 134 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 134 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific HER2-directed Antibody [EPC] | 1 | 0.0122 |
| 1 | Interferon gamma [EPC] | 13 | 0.0092 |
| 2 | Human Blood Coagulation Factor [EPC] | 7 | 0.0085 |
| 3 | Echinocandin Antifungal [EPC] | 35 | 0.0043 |
| 4 | Peroxisome Proliferator-activated Receptor Agonist [EPC] | 3 | 0.0033 |
| 5 | Somatostatin Analog [EPC] | 22 | 0.0032 |
| 6 | Programmed Death Ligand-1 Blocker [EPC] | 69 | 0.0032 |
| 7 | Penem Antibacterial [EPC] | 107 | 0.0031 |
| 8 | Radiographic Contrast Agent [EPC] | 78 | 0.0030 |
| 9 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |